Global Rheumatic Disorders Drugs Market Grow at (CAGR) of 4.46% to $80.04 billion in 2024

Global Rheumatic Disorders Drugs Market to 2024 research report covers key diseases of rheumatic disorders, market size, therapy area overview, etiology, Epidemiology Patterns and Forecasts - Prevalence and Patient Segmentation and key marketed products.

Pune, India - February 12, 2019 /MarketersMedia/ —

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry research report added to ReportsnReports online database.
The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be developed.

Get Discount on Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854866

This report covers all rheumatic disorders, but there is a particular focus on five key diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis, as these conditions have the largest pipelines within the therapy area.

The market size for rheumatic disorder therapeutics was $58.97 billion in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 4.46% to $80.04 billion in 2024.

Scope

- How is the rheumatic disorders market landscape expected to change?
- Which drugs will face patent expiry, biosimilar competition and decreasing revenue over the forecast period?
- Overall, there are 1,069 products in the rheumatic disorder pipeline, how does the composition of the pipeline compare with that of the existing market?
- Which molecular targets are most prominent within the pipeline and how do the key indications differ in terms of their pipeline composition?
- The market size for rheumatic disorder therapeutics is expected to grow, from $58.97 billion in 2017 to $80.04 billion in 2024, at a CAGR of 4.46%. Which products will contribute to market growth most, and which will achieve blockbuster status?
- What types of companies are involved in the rheumatic disorder therapy area?
- Will the current market leaders retain their dominance over the forecast period?
- How many strategic consolidations have been completed in the past decade and which types of assets attract the largest deal values?

Reasons to Buy:
This report will allow you to -
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis for the five key indications
- Understand how the patent expiries of the key, blockbuster anti-TNF drugs will affect the Rheumatic Disorder Drug Market
- Identify trends and developments in the rheumatic disorder pipeline and consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates
- Identify which two drug classes will see particularly strong market growth over the forecast period
- See how or if the companies marketing anti-TNF drugs facing patent expiry will be able to offset biosimilar erosion
- Identify commercial opportunities in the rheumatic disorder deal landscape by analyzing trends in licensing and co-development deals

Direct Purchase of Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854866

Table of Contents:
1. Introduction
2. Key Marketed Products
3. Pipeline Landscape Assessment
4. Multi-scenario Market Forecast to 2024
5. Company Analysis and Positioning
6. Strategic Consolidations
7. Appendix

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854866-global-rheumatic-disorders-drugs-market-to-2024-increased-uptake-of-il-inhibitors-and-jak-inhibitors-to-drive-growth-as-tnf-inhibitors-face-patent-expiry.html

Source URL: https://marketersmedia.com/global-rheumatic-disorders-drugs-market-grow-at-cagr-of-446-to-8004-billion-in-2024/481750

Source: MarketersMedia

Release ID: 481750

Latest News

Police: Aurora gunman likely knew he was being fired

Feb 16, 2019

AURORA, Ill. — The man who gunned down five co-workers and wounded a sixth at a suburban Chicago manufacturing warehouse before shooting and wounding five police officers brought his gun to a meeting in which he was going to be fired, authorities said Saturday. Because Gary Martin brought his gun to Friday's meeting at the sprawling Henry Pratt Co. warehouse in Aurora, he likely knew he might be about to lose the job he had held for 15 years, police Chief Kristen Ziman said at a news conference. Ziman said she didn't know what had been conveyed to Martin, why...

Tear gas, hate speech marks 14th yellow vest protest

Feb 16, 2019

PARIS — Police fired tear gas and brought in water cannons and a horse brigade to disperse several thousand yellow vest protesters Saturday massed near a Paris landmark at the end of a march through the French capital, the 14th straight weekend of demonstrations. Anti-Semitic remarks hurled by a few at a noted philosopher on the protesters' route were the bitter finale to a day of tension. Acrid clouds of tear gas filled the esplanade of Les Invalides monument, obscuring the gold dome that crowns the monument housing Napoleon's tomb. Tension also marked demonstrations in other cities. In Rouen, in...

The Latest: Aurora victim started internship day he died

Feb 16, 2019

AURORA, Ill. — The Latest on the mass shooting at a warehouse in Aurora, Illinois (all times local): 2:15 p.m. One of the five people who were killed by a fired worker at a suburban Chicago industrial warehouse was a 21-year-old college student who had started interning there that day. Jay Wehner says his nephew, Trevor Wehner, began his human resources internship at the Henry Pratt Co. in Aurora on Friday. Authorities say a 45-year-old worker pulled a gun after being fired and fatally shot Wehner and four other employees. They say he wounded a sixth employee and five police...

NBA, FIBA announce plans for pro league in Africa

Feb 16, 2019

CHARLOTTE, N.C. — The NBA is bringing a pro league to Africa. The Basketball Africa League, a new collaboration between the NBA and the sport's global governing body FIBA, was announced Saturday. The initial plan is for the 12-team league to begin play in January, and former President Barack Obama is among those who are expected to have direct involvement with the league's operations. It's yet to be determined which existing club teams will be part of the league. Qualification tournaments will be held later this year to determine those clubs, with teams from Angola, Egypt, Kenya, Morocco, Nigeria, Rwanda,...

The Latest: NBA, FIBA bringing pro league to Africa

Feb 16, 2019

CHARLOTTE, N.C. — The Latest on NBA All-Star Weekend (all times local): 12:50 p.m. The NBA is bringing a pro league to Africa. The Basketball Africa League, a collaboration between the NBA and the sport's global governing body FIBA, was announced Saturday. The initial plan is for the 12-team league to begin play in January. It's yet to be determined which existing club teams will be part of the league. Qualification tournaments will be held later this year to determine those clubs, with teams from Angola, Egypt, Kenya, Morocco, Nigeria, Rwanda, Senegal, South Africa and Tunisia expected to be among...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com